1.03
price up icon0.00%   0.00
after-market After Hours: 1.02 -0.01 -0.97%
loading
Clearmind Medicine Inc stock is traded at $1.03, with a volume of 50,684. It is up +0.00% in the last 24 hours and up +14.46% over the past month. Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$1.03
Open:
$1.03
24h Volume:
50,684
Relative Volume:
0.06
Market Cap:
$4.39M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0241
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
+3.00%
1M Performance:
+14.46%
6M Performance:
-29.93%
1Y Performance:
-37.58%
1-Day Range:
Value
$1.0166
$1.08
1-Week Range:
Value
$1.00
$1.25
52-Week Range:
Value
$0.80
$2.18

Clearmind Medicine Inc Stock (CMND) Company Profile

Name
Name
Clearmind Medicine Inc
Name
Phone
-
Name
Address
-
Name
Employee
1
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CMND's Discussions on Twitter

Compare CMND with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CMND
Clearmind Medicine Inc
1.03 5.54M 0 -6.78M -4.67M -42.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Clearmind Medicine Inc Stock (CMND) Latest News

pulisher
02:25 AM

Clearmind Medicine Inc. Stock Analysis and ForecastRapidly expanding wealth - PrintWeekIndia

02:25 AM
pulisher
Jul 24, 2025

Is Clearmind Medicine Inc. a good long term investmentHigh-performance investment picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Why TRUMP(maga) Will ExplodeMarket Ready Callouts - Newser

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Clearmind Medicine Inc. stock priceExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Clearmind Medicine Inc. stockPowerful growth strategies - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Clearmind Medicine Inc Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - MarketScreener

Jul 23, 2025
pulisher
Jul 23, 2025

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Clearmind advances AUD treatment with new trial site in Tel Aviv - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Clearmind Medicine Inc. Announces Successful Site Initiation for Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center - Nasdaq

Jul 23, 2025
pulisher
Jul 21, 2025

Clearmind Medicine Surges 18.99%: What's Fueling This Volatile Biotech Rally? - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 16, 2025
pulisher
Jul 15, 2025

How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times

Jul 15, 2025
pulisher
Jul 09, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance

Jul 09, 2025
pulisher
Jul 04, 2025

Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq

Jul 03, 2025

Clearmind Medicine Inc Stock (CMND) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Cap:     |  Volume (24h):